BerandaIDP • ETR
add
Biogen Inc
Tutup sebelumnya
€142,05
Rentang hari
€140,45 - €143,60
Rentang tahun
€131,60 - €231,00
Kapitalisasi pasar
21,20 M USD
Volume Rata-Rata
529,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
The Business Journals
1 hari yang lalu
Sage rejects Biogen’s buyout offer, but says it's open to deals
2,20%
1,21%
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 2,47 M | -2,55% |
Biaya operasional | 1,32 M | -17,78% |
Laba bersih | 388,50 jt | 670,48% |
Margin laba bersih | 15,76 | 685,87% |
Penghasilan per saham | 4,08 | -6,42% |
EBITDA | 694,20 jt | 75,52% |
Tarif pajak efektif | 13,86% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,70 M | -25,73% |
Total aset | 28,31 M | 0,43% |
Total liabilitas | 11,95 M | -12,83% |
Total ekuitas | 16,36 M | — |
Saham yang beredar | 145,72 jt | — |
Harga terhadap nilai buku | 1,27 | — |
Tingkat pengembalian aset | 4,64% | — |
Tingkat pengembalian modal | 5,61% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 388,50 jt | 670,48% |
Kas dari operasi | 935,60 jt | 57,93% |
Kas dari investasi | -1,18 M | 32,21% |
Kas dari pembiayaan | -6,60 jt | -100,78% |
Perubahan kas bersih | -209,70 jt | 36,44% |
Arus kas bebas | 997,75 jt | 617,87% |
Tentang
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
Didirikan
1978
Kantor pusat
Situs
Karyawan
7.570
